Skip to main content
. 2020 Mar 5;10:4134. doi: 10.1038/s41598-020-60904-8

Figure 5.

Figure 5

Gal-3 produced from HSCs with P.g.-infection or LPS-PG enhances sensitivity to TGF-β1 via upregulating TGF-β receptor II expression. LX-2 cells with/without palmitate treatment were cultured with (a) P.g. (MOI-100) or (b) LPS-PG (1 μg/ml) for 2 days. Gal-3 expression was analyzed by western blotting. (c) LX-2 cells with/without palmitate treatment were cultured with recombinant human Gal-3 (1 µg/ml) for 3 days. α-SMA, Smad2, Smad3, and ERK1/2 were detected by western blotting. (d) LX-2 cells with/without palmitate treatment were cultured with Gal-3 (1 µg/ml) for 2 days. TGF-β receptor II was detected by western blotting. β-actin was used as internal control. Pal: palmitate, Gal-3: Galectin-3.